Skip to main content

2024 Collections

Novel Biomarkers and Cellular Mechanisms in Breast Cancer: Insights from In Vitro and In Vivo Single-Cell Studies Call for Papers

We are proud to announce a collection edited by Shicong Tang. This collection will showcase pioneering research utilizing single-cell transcriptomics to reveal novel biomarkers and elucidate cellular mechanisms underpinning breast cancer progression and treatment responses. The studies will encompass both in vitro and in vivo research, focusing on metabolic and immunological heterogeneity within the tumor microenvironment. 

Human Cancer Proteoforms Call for Papers

We are proud to announce a collection edited by Andy T. Y. Lau and Amy Yan-Ming Xu. We welcome articles on a range of topics including, but not limited to: novel functions of cancer-specific and systematic analysis of human proteoforms; cancer-specific proteoforms as diagnostic biomarkers or therapeutic targets, and the development of novel strategies to modulate proteoforms function in cancer therapy. 


Announcing the launch of In Review

Cancer Cell International, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. Read more here.


Yasumasa Kato, Ohu University, Japan
Andy TY Lau, Shantou University Medical College, China

Celebrating 20 years

2021 marked the 20th year since Cancer Cell International published its very first articles. To mark the occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 20 years.

Trending articles

Click here to view which articles have been shared the most in the last month!

Springer Nature Oncology Portfolio

Discover the range of academic oncology titles at Springer Nature here.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 5.3
    5-year Journal Impact Factor: 5.0
    Source Normalized Impact per Paper (SNIP): 0.920
    SCImago Journal Rank (SJR): 1.257

    Speed 2023
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 110

    Usage 2023
    Downloads: 2,067,719
    Altmetric mentions: 1,052

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here